找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Cardiovascular Pharmacology of 5-Hydroxytryptamine; Prospective Therapeu P. R. Saxena,D. I. Wallis,P. Bevan Book 1990 Springer Science+Busi

[復(fù)制鏈接]
查看: 31082|回復(fù): 56
樓主
發(fā)表于 2025-3-21 18:35:20 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱Cardiovascular Pharmacology of 5-Hydroxytryptamine
副標(biāo)題Prospective Therapeu
編輯P. R. Saxena,D. I. Wallis,P. Bevan
視頻videohttp://file.papertrans.cn/222/221973/221973.mp4
叢書名稱Developments in Cardiovascular Medicine
圖書封面Titlebook: Cardiovascular Pharmacology of 5-Hydroxytryptamine; Prospective Therapeu P. R. Saxena,D. I. Wallis,P. Bevan Book 1990 Springer Science+Busi
出版日期Book 1990
關(guān)鍵詞cardiovascular; pharmacology
版次1
doihttps://doi.org/10.1007/978-94-009-0479-8
isbn_softcover978-94-010-6701-0
isbn_ebook978-94-009-0479-8Series ISSN 0166-9842
issn_series 0166-9842
copyrightSpringer Science+Business Media Dordrecht 1990
The information of publication is updating

書目名稱Cardiovascular Pharmacology of 5-Hydroxytryptamine影響因子(影響力)




書目名稱Cardiovascular Pharmacology of 5-Hydroxytryptamine影響因子(影響力)學(xué)科排名




書目名稱Cardiovascular Pharmacology of 5-Hydroxytryptamine網(wǎng)絡(luò)公開度




書目名稱Cardiovascular Pharmacology of 5-Hydroxytryptamine網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Cardiovascular Pharmacology of 5-Hydroxytryptamine被引頻次




書目名稱Cardiovascular Pharmacology of 5-Hydroxytryptamine被引頻次學(xué)科排名




書目名稱Cardiovascular Pharmacology of 5-Hydroxytryptamine年度引用




書目名稱Cardiovascular Pharmacology of 5-Hydroxytryptamine年度引用學(xué)科排名




書目名稱Cardiovascular Pharmacology of 5-Hydroxytryptamine讀者反饋




書目名稱Cardiovascular Pharmacology of 5-Hydroxytryptamine讀者反饋學(xué)科排名




單選投票, 共有 1 人參與投票
 

0票 0.00%

Perfect with Aesthetics

 

1票 100.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 21:07:50 | 只看該作者
板凳
發(fā)表于 2025-3-22 00:58:38 | 只看該作者
地板
發(fā)表于 2025-3-22 04:44:56 | 只看該作者
Diophantine Aspects of Elliptic Curvesne (5-HT) receptor subtype to be understood at the amino acid sequence level [3, 4]. The strategy used to clone the 5-HT. receptor is a powerful new approach to molecular cloning, which will be broadly applicable to many receptor and ion channel proteins. The basics of this strategy will be reviewed
5#
發(fā)表于 2025-3-22 09:56:35 | 只看該作者
6#
發(fā)表于 2025-3-22 15:49:53 | 只看該作者
Diophantine Aspects of Elliptic Curvesctive antagonist methiothepin and a resistance to blockade by ketanserin and MDL 72222. In our view, application of such exclusion criteria establishes what the receptor is not rather than what it is.
7#
發(fā)表于 2025-3-22 20:01:59 | 只看該作者
Benjamin Fine,Gerhard Rosenberger5-HT receptor types by Bradley et al. [4] has enabled studies of central functional receptors to 5-HT. However, lack of selective antagonists at the 5-HT.like receptor continues to inhibit proper definition of 5-HT actions in the CNS.
8#
發(fā)表于 2025-3-23 01:04:47 | 只看該作者
9#
發(fā)表于 2025-3-23 02:34:24 | 只看該作者
10#
發(fā)表于 2025-3-23 06:58:11 | 只看該作者
Introduction to Diophantine Equationsstances of unsurmountable antagonism, to discuss possible mechanisms involved, and to present data suggesting that pseudoirreversible antagonism best explains unsurmountable antagonism of 5-HT-induced vasoconstriction in the isolated perfused rat kidney. Finally, the utility of antagonist probes for receptor classification will be discussed.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-11 09:45
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
年辖:市辖区| 沛县| 灵丘县| 攀枝花市| 汾西县| 阳谷县| 读书| 朝阳市| 龙泉市| 长乐市| 紫金县| 福泉市| 金阳县| 荔波县| 通许县| 冕宁县| 岳普湖县| 营口市| 如东县| 黄山市| 平和县| 太白县| 沂南县| 庄河市| 山阳县| 绥化市| 河池市| 肇东市| 祁阳县| 贵定县| 朝阳区| 阳新县| 三江| 怀宁县| 德兴市| 邳州市| 明光市| 卓资县| 睢宁县| 威宁| 临沧市|